Aims-Intestinal trefoil factor is a mucosa associated trefoil peptide expressed predominantly in the goblet cells of the small and large intestine. The aim of this work was to investigate the expression of the intestinal trefoil factor gene in human colorectal cancers. Methods-The expression of intestinal trefoil factor mRNA was examined by northern blot analysis in 27 cases of surgically resected primary colorectal carcinoma of various stages. Results-Although intestinal trefoil factor mRNA was expressed consistently in the tumours, the levels of expression varied considerably among the cases examined. The levels of expression were low in advanced stage tumours (Dukes's B, C, and D) compared with early stage tumours (Dukes's A) (p < 0.05). In addition, there was a tendency towards a positive correlation, albeit not well defined, between the amounts of intestinal trefoil factor mRNA and the histological differentiation of tumours. Conclusions-Intestinal trefoil factor mRNA was expressed consistently in the cases of colorectal carcinoma studied and expression was inversely associated with tumour progression. (7 Clin Pathol 1997;50:932-934) 
Intestinal trefoil factor is a small peptide bearing the unique motif of intrachain disulphide bonds characteristic of the trefoil family. This molecule is localised primarily within goblet cells in the small and large bowel.'-' The pattern of intestinal trefoil factor expression is altered at sites of ulceration in the intestinal tract,3-5 suggesting that intestinal trefoil factor protects against ulcerative damage or has an important role in regeneration of the damaged mucosa. Indeed, targeting disruption of the intestinal trefoil factor gene in mice resulted in impairment of mucosal healing and epithelial regeneration. 6 Experimental evidence suggests that intestinal trefoil factor is a motogen, capable of promoting the migration of epithelial cells.7 To date, three human trefoil peptides have been described: pS2, spasmolytic polypeptide, and intestinal trefoil factor. Although little is known about the functional roles of these peptides in cancer, pS2 was identified as an oestrogen induced gene in a human breast carcinoma cell line, MCF-7, and has been reported to be expressed by various solid tumours such as carcinomas of the breast, stomach, pancreas, biliary tract, and colorectum.8 Recently, the presence of immunoreactive intestinal trefoil factor peptides was reported not only in normal colonic mucosa but also in colonic adenomas and carcinomas, and the amounts correlated with the degree of histological differentiation of the neoplastic tissues.9 However, the immunodetection may detect absorbed intestinal trefoil factor in addition to synthesised factor. For instance, immunostaining studies indicate that intestinal trefoil factor is present in goblet cells and absorptive enterocytes in the small and large intestine,2 whereas in situ hybridisation revealed that intestinal trefoil factor mRNA is abundant in goblet cells only.2 The aim of this study was to examine the presence of intestinal trefoil factor mRNA in colorectal carcinoma and to compare its level of expression with that found in the corresponding normal mucosal tissue. We report here that intestinal trefoil factor mRNA is expressed consistently in colorectal carcinoma, and that the level of expression of mRNA may be inversely related to the disease progression.
Methods
All tissue was received freshly from the operating room. The cases analysed were 27 primary colorectal carcinomas. In each case, tissue samples were taken from the primary tumour tissue and corresponding normal mucosal tissue. Total cellular RNA was extracted from the tissue samples using Trizol reagent (Gibco BRL, Gaithersburg, Maryland, USA). The extracted total RNA (30 gg) was electrophoresed through a formaldehyde containing 1% agarose gel. The products of electrophoresis were transferred on to a Hybond N+ nylon membrane (Amersham, Buckinghamshire, UK) and the RNA was UV crosslinked on to the membrane. Hybridisation was performed in a mixed solution of 50% formamide, 5x Denhardt's solution, 25 mM phosphate buffer (pH 6.5), 0.1% sodium dodecyl sulphate (SDS), 100 jg/ml of sonicated and heat denatured salmon sperm DNA, and 5x standard saline citrate (SSC) at 42°C for 16 hours. The blots were washed as follows: three times in lx SSC containing 0.1% SDS for 10 minutes at room temperature, followed by three times Expression of intestinal trefoilfactor mRNA in colorectal carcinoma tle is known about the expression and biological significance of intestinal trefoil factor in tumours. Recently, Taupin et al reported the presence of immunoreactive intestinal trefoil factor proteins in the colonic adenoma carcinoma sequence and showed that levels of immunoreactive intestinal trefoil factor in well or moderately well differentiated tumours were higher than those in poorly differentiated tumours. 9 In the present study, we confirmed that intestinal trefoil factor mRNA is, in fact, expressed in colorectal carcinomas as well as in normal mucosa, and the levels of mRNA were inversely associated with the progression of the tumours. Therefore, our findings are in accordance with those of Taupin et al. 9 As mentioned by Taupin et al,9 the detection of the intestinal trefoil factor peptide and/or mRNA may have diagnostic value for an intestinal origin in metastatic adenocarcinoma in which the primary site is unknown. 
